Sugi Predict

Sugi Predict / Compounds / SCHEMBL617140

SCHEMBL617140

SCHEMBL617140

CCCCCCCCCCCCNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.48
▸ ANPEP P15144 1/20 0.45
▸ ERAP2 Q6P179 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ LMNA P02545 3/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ SPHK1 Q9NYA1 1/20 0.39
▸ GMNN O75496 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ THPO P40225 1/20 0.39
▸ MTOR P42345 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CETP P11597 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665839 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL3673155 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL6012839 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL14118625 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL3801934 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL7275105 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL17678369 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL12510924 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL8433089 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL11328260 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112142805-B N-alkylglucosamine small-molecule alcohol gel and preparation method and application thereof 江南大学 2022-03-25 — — CN claimed
US-9040513-B2 Process for preparing platinum-carbene complexes CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2015-05-26 — — US claimed
US-20140131258-A1 METHOD FOR REMOVING OIL OrganoPetroleum PSP AB (SE) 2014-05-15 — — US claimed
US-20140058061-A1 PROCESS FOR PREPARING PLATINUM-CARBENE COMPLEXES ULNIVERSITE DE STRASBOUGE (FR) 2014-02-27 — — US claimed
US-20140057887-A1 NOVEL PLATINUM-CARBENE COMPLEXES AND USE THEREOF AS MEDICAMENTS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-02-27 — — US claimed
US-4269857-A 1-DEOXY-1-N-ALKYLAMINO REDUCED MONOSACCHARIDES OR AMINE SALTS; ALSO GLYCOPYRANOSYL DERIVATIVES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1981-05-26 — — US claimed
JP-55062004-A — — None — — JP disclosed
CN-117899269-A Anti-calcification method of bioprosthetic tissue and bioprosthetic tissue 上海微创心通医疗科技有限公司 2024-04-19 — — CN disclosed
CN-115155662-B Method for preparing aromatic amine compound by hydrogenation of aromatic nitro compound and preparation method of palladium catalyst thereof 江南大学 2023-09-08 — — CN disclosed
US-10736325-B2 Surfactants and formulations MONSANTO TECHNOLOGY LLC (US) 2020-08-11 — — US disclosed
EP-3284809-B1 CLEANING COMPOSITION PROCTER & GAMBLE (US) 2019-09-25 — — EP disclosed
US-9969762-B2 Method for synthesizing N-alkyl-glycosyl(di)amine derivatives and uses of same against phytopathogens SIPRE (FR) 2018-05-15 — — US disclosed
EP-2782921-B1 ORGANIC TUNGSTEN COMPLEXES VANDERBILT CHEMICALS LLC (US) 2018-05-02 — — EP disclosed
US-4395571-A Process for the preparation of d,1-2-(6-methoxy-2-naphthyl)propionic acid SYNTEX (U.S.A.) INC. (US) 1983-07-26 — — US disclosed
EP-0022529-B1 PROCESS FOR THE RESOLUTION OF D,L 2-(6-METHOXY-2-NAPHTHYL)PROPIONIC ACID; A MIXTURE OF THE SALTS OF THESE D AND L ACIDS; A PHARMACEUTICAL COMPOSITION CONTAINING A SALT OF THE D ACID; A SALT OF THE D ACID SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) 1983-06-29 — — EP disclosed
US-4269857-A 1-DEOXY-1-N-ALKYLAMINO REDUCED MONOSACCHARIDES OR AMINE SALTS; ALSO GLYCOPYRANOSYL DERIVATIVES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1981-05-26 — — US disclosed
EP-0022529-A1 Process for the resolution of d,l 2-(6-methoxy-2-naphthyl)propionic acid; a mixture of the salts of these d and l acids; a pharmaceutical composition containing a salt of the d acid; a salt of the d acid SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) 1981-01-21 — — EP disclosed
US-4246193-A USING N-ALKYL-D-GLUCAMINE TO FORM A SALT SYNTEX CORPORATION (PA) 1981-01-20 — — US disclosed
JP-S5562004-A CONTROL AGENT AGAINST PLANT VIRAL DISEASE KUREHA CHEM IND CO LTD 1980-05-10 — — JP disclosed
US-4021539-A Skin treating cosmetic compositions containing N-polyhydroxyalkyl-amines HENKEL & CIE G.M.B.H. (DT) 1977-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140058061-A1 PROCESS FOR PREPARING PLATINUM-CARBENE COMPLEXES PMS2, PCBP1, PARG KDM4E 4207/4885ANPEP 2952/4885ERAP2 3679/4885
US-20140057887-A1 NOVEL PLATINUM-CARBENE COMPLEXES AND USE THEREOF AS MEDICAMENTS PMS2, MSH2, GPX4 KDM4E 4747/4885ANPEP 3025/4885ERAP2 368/4885
US-10736325-B2 Surfactants and formulations PHOSPHO1, GNMT, DDT KDM4E 651/4885ANPEP 459/4885ERAP2 2135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.